Crédit Agricole Création
Investor profile
Venture capital
Also recorded as: Credit Agricole Creation
Deals
8
distinct rounds
Companies
7
backed
Active span
2018–2024
7 yrs
Total round €
€227M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Kreaxi3
- Elaia Partners2
- Fondation Fournier-Majoie2
- Sham Innovation Santé2
- Simba Santé2
- Sofinnova Partners2
- Andera Partners1
- ATEM1
- Auriga Cyber Ventures1
- Axeleo Capital1
- BNP Paribas Développement1
- Crédit Mutuel Innovation1
- CTI Life Sciences1
- EIT InnoEnergy1
- EQT Life Sciences1
- Evolem Start1
- Innobio 21
- Intermediate Capital Group1
- Kurma Partners1
- Mass General Brigham Ventures1
- Mérieux Equity Partners1
- Novo Holdings1
- Omnes Capital1
- OneRagtime1
- OrbiMed1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Amolyt Pharma | France | 1 | €129M |
| Mecaware | France | 1 | €40M |
| Mablink Bioscience | France | 2 | €35M |
| ProovStation | France | 1 | €10M |
| Tenacy | France | 1 | €6.0M |
| Tilkee | France | 1 | €3.5M |
| Aster | France | 1 | €3.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Mecaware | Other | €40M | 2023-10 |
| Mablink Bioscience | Series A | €31M | 2022-10 |
| ProovStation | Series A | €10M | 2023-01 |
| Tenacy | Other | €6.0M | 2024-01 |
| Mablink Bioscience | Seed | €4.0M | 2021-04 |
| Tilkee | Other | €3.5M | 2018-01 |
| Aster | Other | €3.0M | 2021-09 |